涂召旭(副研究员,博士生导师)

中山大学“百人计划”特聘副研究员,博士生导师,德国柏林自由大学博士(优等博士学位,top 1%),美国哥伦比亚大学博士后。
主要研究方向为“上气道炎症机制及靶向治疗”,目前发表高水平论文20余篇,单篇最高影响因子83.5,论文累计应用次数约1800次。其中第一及通讯作者发表杂志包括Nature Review Materials (中科院1区,IF=83.5), Advanced Materials(中科院1区,IF=32.8), Advanced Functional Materials(4篇,中科院1区,IF=19.9), ACS NANO(中科院1区,IF=18.0),Angewandte Chemie(中科院1区,IF=16.8)等,Advanced Functional Materials(3篇,中科院1区,IF=15.1)。同时获授权中国发明专利2项,多次受邀在国际学术会议做口头报告,担任Adv. Mat., Adv. Funct. Mat., Angew. Chem.和Biomaterials等杂志特邀审稿人。


教育背景:
(1) 2014-09 至 2018-07, 德国,柏林自由大学,博士
(2) 2011-09 至 2014-06, 中国,四川大学,硕士
(3) 2007-09 至 2011-06, 中国,四川大学,学士 


科研工作经历:

(1)2021-11 至 今, 中山大学, 附属第六医院, 副研究员/博士生导师
(2) 2018-11 至 2021-10, 美国,哥伦比亚大学
(3) 2018-08 至 2018-10, 德国,柏林自由大学


团队研究方向:
1.上气道难治性炎症疾病的炎症机制;
2.上气道炎症疾病的纳米靶向治疗技术。


代表性论文代表性项目荣誉

10篇代表性论文(第一作者及通讯作者):
(1) Zhaoxu Tu*, M. Liu, C. Xu, Y. Wei, T. Lu, Y. Xiao, H. Li, S. Zhang, X. Xie, Jian Li*, Weiping Wen*, Functional 2D nanoplatforms alleviate eosinophilic chronic rhinosinusitis by modulating eosinophil extracellular trap formation, Adv. Sci. 2024, 11, (中科院1区,影响因子:15.1)
(2) Zhaoxu Tu*, Y. Zhu, W. Gao, M. Liu, Y. Wei, C. Xu, Y. Xiao, Y. Wen, J. Li, Kam W. Leong*, and Weiping Wen*, Tackling Severe Neutrophilic Inflammation in Airway Disorders with Functionalized Nanosheets, ACS NANO 2024, 18, 7084. (中科院1区,影响因子:17.1)
(3) Y. Xiao, H. Fang, Y. Zhu, J. Zhou, Z. Dai, H. Wang, Zhaofan Xia*, Zhaoxu Tu*, and Kam W. Leong*, Multifunctional Cationic Hyperbranched Polyaminoglycosides that Target Multiple Mediators for Severe Abdominal Trauma Management, Adv. Sci. 2024, 11, 2305273. (中科院1区,影响因子:17.8)
(4) K. Wu, X. Lu, Y. Li, Y. Wang, M. Liu, H. Li, H. Li, Q. Liu, D. Shao, W. Chen, Y. Zhou*, Zhaoxu Tu*, and H. Mao*, Polyglycerol-Amine Covered Nanosheets Target Cell-Free DNA to Attenuate Acute Kidney Injury, Adv. Sci. 2023, 10, 2300604. (中科院1区,影响因子:17.8)
(5) Zhaoxu Tu, Yuefei Zhu, Yongqiang Xiao, Jie Chen, Sydney Shannon, Fan Zhang, Zhengwei Li, Jie Zhou, Hanze Hu, Tie-Cho Ho, Wenlong Gao, Dan Shao, Kam W. Leong, Scavenging tumor-derived small extracellular vesicles by functionalized 2D materials to inhibit tumor regrowth and metastasis following radiotherapy, Advanced Function al Materials,2022, 32, 2205663. (中科院1区,影响因子:19.9)
(6) Zhaoxu Tu; Yiling Zhong; Hanze Hu; Dan Shao; Rainer Haag; Michael Schirner; Jaewoo Lee; B ruce Sullenger; Kam W. Leong ; Design of therapeutic biomaterials to control inflammation, Nature Review Materials, 2022,7, 557-574(中科院1区,影响因子:83.5)
(7) Zhaoxu Tu; Ievgen S. Donskyi; Haishi Qiao; Zhonglin Zhu; Wolfgang E. S. Unger; Christian P. R. Hackenberger; Wei Chen; Mohsen Adeli; Rainer Haag ; Graphene Oxide-Cyclic R10 Peptide Nucle ar Translocation Nanoplatforms for the Surmounting of Multiple-Drug Resistance, Advanced Function al Materials, 2020, 30(35) (中科院1区,影响因子:19.9)
(8) Zhaoxu Tu; Haishi Qiao; Yuting Yan; Guy Guday; Wei Chen; Mohsen Adeli; Rainer Haag ; Dire cted Graphene-Based Nanoplatforms for Hyperthermia: Overcoming Multiple Drug Resistance, Angewand te Chemie International Edition, 2018,57,11198-11202 (中科院1区,影响因子:16.8)
(9) Zhaoxu Tu; Katharina Achazi; Andrea Schulz; Rolf Mülhaupt; Steffen Thierbach; Eckart Rühl ; Mohsen Adeli; Rainer Haag ; Combination of Surface Charge and Size Controls the Cellular Uptake of Functionalized Graphene Sheets, Advanced Functional Materials, 2017, 27,1701837-1701837 (中科院1区,影响因子:19.9)
(10) Zhaoxu Tu; Guy Guday; Mohsen Adeli; Rainer Haag ; Multivalent Interactions between 2D Nan omaterials and Biointerfaces, Advanced Materials, 2018, 30,1706709(中科院1区,影响因子:32.8)